[1]
“AGGREGATE ANALYSIS OF FDI IMPACT ON GROWTH IN SELECTED PHARMACEUTICAL FIRMS”, TURCOMAT, vol. 10, no. 3, pp. 1685–1692, Dec. 2019, doi: 10.61841/turcomat.v10i3.14668.